![]() |
**__Related stories:__***linkurl:Expert advice on surviving $ mess;http://www.the-scientist.com/blog/display/55191/
[13th November 2008]*linkurl:Chasing Challenges;http://www.the-scientist.com/2008/9/1/69/1/
[September 2008]
Drug maker AstraZeneca is pink-slipping approximately 550 Wilmington, Delaware-based researchers and their support staff in a move to help balance the company's books and save it $1.9 billion per year by 2014. Image: B.gliwa via Wikipedia CommonsThe company told the linkurl:__Philadelphia Inquirer__;http://www.philly.com/philly/business/86127882.html yesterday (March 3rd) that the layoffs are part of a plan to shutter an entire research group, focused on identifying candidate compounds for psyc
![]() |


From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.

Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes

Designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns

Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud